David Nanchen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Circulation. Cardiovascular quality and outcomes

Revue medicale suisse

Advances in therapy

PloS one

Center for Primary Care and Public Health, University of Lausanne

Nihes - Netherlands Institute for Health Sciences (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Center for Primary Care and Public Health, University of Lausanne

Switzerland

Médecin-adjoint :: Health promotion and prevention

Education History

Nihes - Netherlands Institute for Health Sciences

Netherlands

MSC :: Clinical epidemiology

Publications

Kristina Krasieva, Baris Gencer, Isabella Locatelli, David Carballo, Olivier Müller, Stéphane Fournier, Christian M Matter, Lorenz Räber, Nicolas Rodondi, François Mach, David Nanchen
Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome. Circulation. Cardiovascular quality and outcomes 17 (8) (2024)
Kristina Krasieva, Baris Gencer, Isabella Locatelli, David Carballo, Olivier Müller, Stéphane Fournier, Christian M Matter, Lorenz Räber, Nicolas Rodondi, François Mach, David Nanchen
Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome. Circulation. Cardiovascular quality and outcomes (2024)
Kristina Krasieva, Baris Gencer, Isabella Locatelli, David Carballo, Olivier Müller, Stéphane Fournier, Christian M Matter, Lorenz Räber, Nicolas Rodondi, François Mach, David Nanchen
Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome. Circulation. Cardiovascular quality and outcomes 17 (8) (2024)
Paul Tarteret, David J T Campbell, Sophie Vassaux, John Prior, Roger Darioli, David Nanchen
[Mobile cardiovascular screening and prevention in the population : useful in Switzerland?] Revue medicale suisse 20 (864) (2024)
Olivier Emery, David Nanchen, Jonviea D Chamberlain
[Epigenetic modifications and cardiovascular diseases : new Eldorado]. Revue medicale suisse 20 (864) (2024)
Christian Valentin Eisenring, Preci L Hamilton, Philippe Herzog, Markus F Oertel, Isabelle Jacot-Sadowski, Felice Burn, Jacques Cornuz, Bawarjan Schatlo, David Nanchen
Nicotine Replacement Therapy for Smokers with Acute Aneurysmal Subarachnoid Hemorrhage: An International Survey. Advances in therapy 39 (11) (2022)
David Nanchen, David Carballo, Stefan Bilz, Hans Rickli, Konstantinos C Koskinas, François Mach, Christian E Mueller, Carmela Crljenica, Mariagrazia Rossi, Nina Reichert, Isabella Sudano
Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study. Advances in therapy (2021)
Roland Klingenberg, Soheila Aghlmandi, Lorenz Räber, Alexander Akhmedov, Baris Gencer, David Carballo, David Nanchen, Heiner C Bucher, Nicolas Rodondi, François Mach, Stephan Windecker, Ulf Landmesser, Arnold Von Eckardstein, Christian W Hamm, Thomas Felix Lüscher, Christian M Matter
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes. Journal of the American Heart Association 10 (20) (2021)
Silvia Canivell, Olivier Muller, Baris Gencer, Dik Heg, Roland Klingenberg, Lorenz Räber, David Carballo, Christian Matter, Thomas Lüscher, Stephan Windecker, François Mach, Nicolas Rodondi, David Nanchen
Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome. PloS one 13 (4) (2018)

David Nanchen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Nanchen